Mindfulness-based program for stress reduction in infertile women: Randomized controlled trial

Stress Health. 2019 Feb;35(1):49-58. doi: 10.1002/smi.2839. Epub 2018 Oct 16.

Abstract

Infertile women often experience chronic stress, which may have a negative impact on general well-being and may increase the burden of infertility. In this open-label, parallel, randomized controlled trial, infertile women aged 18-50 years (median 37 years) were assigned to an 8-week mindfulness-based program (MBP) or no intervention. The primary outcome was stress severity measured by the Lipp's Stress Symptoms Inventory (ISSL). Data were analyzed by modified intent-to-treat principle, which included all cases available to follow-up regardless of adherence to the intervention (62 participants from the MBP group and 37 from the control group). The median number of symptoms of chronic stress recorded in the past month decreased from six (interquartile range 2 to 9) before the MBP to two (interquartile range 1 to 4) after the intervention (p < 0.001, repeated measures analysis of variance with Time × Group interaction). Depressive symptoms also decreased after MBP, whereas general well-being improved (p < 0.01 for both outcomes). Hair cortisol and serum brain-derived neurotrophic factor (BDNF) did not change significantly between preintervention and postintervention. None of the outcomes changed significantly in the control group. MBP was effective in reducing stress and depressive symptoms while increasing general well-being in infertile women.

Keywords: BDNF; cortisol; depression; infertility; mindfulness; quality of life; stress.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Brain-Derived Neurotrophic Factor / blood
  • Brazil
  • Depression / therapy*
  • Female
  • Hair / chemistry
  • Humans
  • Hydrocortisone / chemistry
  • Infertility, Female / psychology*
  • Middle Aged
  • Mindfulness*
  • Psychiatric Status Rating Scales
  • Quality of Life
  • Stress, Psychological / therapy*
  • Surveys and Questionnaires
  • Treatment Outcome
  • Young Adult

Substances

  • Brain-Derived Neurotrophic Factor
  • Hydrocortisone